Skip to main content
Premium Trial:

Request an Annual Quote

Xyris Appoints Kim as Chief Technical Officer

Premium

SAN DIEGO, Calif.--Xyris, the Axys Pharmaceuticals affiliate established earlier this year to apply the pharmaceutical company's proprietary bioinformatics and research technologies to the agriculture industry, has named Leo Kim as chief technical officer. Kim joined Xyris from Mycogen, where he had been responsible for worldwide research since 1986. In his new position he will oversee Xyris's research efforts. Prior to joining Mycogen, Kim was the highest ranking biotechnology scientist at Shell Development.

John Walker, Axys's CEO, commented, "Dr. Kim's knowledge and experience will have an immediate impact on the growth of Xyris and the implementation of Axys's technology platform."

Filed under

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.